⌘K
Loading ticker…
As of 2026-08-21, Tvardi Therapeutics, Inc. Common Stock (TVRD) has a 3-month relative strength percentile of 7 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 30. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.5%, relative volume 0.48×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TVRD is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -23.0% / -45.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
TVRD is held by 8 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $103K notional. Top 3 carry $118K.
Held by 15 ETFs · $2M across latest filings · largest weight 0.04% (IWC).
Top 8 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.00% | $103K | — |
| VTWV | 0.00% | $13K | — |
| VTWG | 0.00% | $2K | — |
| ITWO | 0.00% | $960 | — |
| URTY | 0.00% | $750 | — |
| UWM | 0.00% | $744 | — |
| HDG | 0.00% | $20 | — |
| RB | 0.00% | $3 | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TVRD Jan avg: -7.67% median: -7.67% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 | TVRD Feb avg: 0.50% median: 0.50% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 | TVRD Mar avg: -20.30% median: -20.30% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 | TVRD Apr avg: 17.86% median: 17.86% win: 50% σ: 26.60% n: 2 2025-04-17 → 2026-07-31 | TVRD May avg: 10.47% median: 10.47% win: 100% σ: 4.48% n: 2 2025-04-17 → 2026-07-31 | TVRD Jun avg: -30.73% median: -30.73% win: 0% σ: 18.46% n: 2 2025-04-17 → 2026-07-31 | TVRD Jul avg: 10.90% median: 10.90% win: 100% σ: 0.53% n: 2 2025-04-17 → 2026-07-31 | TVRD Aug avg: 15.25% median: 15.25% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 (current) | TVRD Sep avg: 30.25% median: 30.25% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 | TVRD Oct avg: -88.07% median: -88.07% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 | TVRD Nov avg: -11.40% median: -11.40% win: 0% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 | TVRD Dec avg: 4.37% median: 4.37% win: 100% σ: 0.00% n: 1 2025-04-17 → 2026-07-31 |